Pharmacovigilance and herbal medicines safety: a cross-sectional study of healthcare professionals’ knowledge, attitudes and practices in selected regions of Tanzania, 2021
Alambo K. Mssusa, Godeliver Kagashe, Sheila Maregesi, Lone Holst

TL;DR
This study in Tanzania found that healthcare professionals have low knowledge and limited practice in reporting safety issues related to herbal medicines, despite generally positive attitudes.
Contribution
The study provides empirical evidence on gaps in pharmacovigilance knowledge and reporting practices specific to herbal medicines among healthcare professionals in Tanzania.
Findings
Most healthcare professionals (65.8%) had low knowledge of pharmacovigilance and herbal medicine adverse drug reactions.
Only 22.9% of healthcare professionals actively reported adverse drug reactions, with only 18.4% involving herbal medicines.
Professional background significantly influenced knowledge of pharmacovigilance and herbal medicine safety.
Abstract
The World Health Organization recommends integrating the safety monitoring of herbal medicines into existing pharmacovigilance (PV) systems to avoid overburdening the healthcare systems and national PV centres. However, there are few reports (0.3%) of herbal medicine Adverse Drug Reactions (ADRs) in the global database originating from Africa. An efficient PV system requires the involvement and commitment of healthcare professionals since they are primary contacts in transferring safety information from patients and consumers to national regulatory authorities (NRAs). The aim of this study was to determine the healthcare professionals’ knowledge, attitudes and practices regarding PV and herbal medicine safety in Tanzania. An observational, cross-sectional, multicentre study was conducted in five regions of Tanzania, involving healthcare professionals working in pharmacies, hospitals,…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPharmacovigilance and Adverse Drug Reactions · Antibiotic Use and Resistance · Pharmaceutical Practices and Patient Outcomes
